Utilization of111In-Capromab pendetide SPECT-CT for detecting seminal vesicle invasion with recurrent prostate cancer after primaryin situtherapy
Open Access
- 1 December 2009
- journal article
- Published by Wiley in International Journal of Urology
- Vol. 16 (12) , 971-975
Abstract
The aim of this study was to evaluate the diagnostic value of a hybrid (111)In-capromab pendetide fused computed tomography (CT) scan in detecting seminal vesicle invasion (SVI) in the setting of recurrent prostate cancer following primary in situ therapy. The study population comprised 59 patients, who biochemically failed primary in situ treatment based on American Society for Therapeutic Radiology and Oncology criteria. The patients underwent an (111)In-capromab pendetide/CT scan at the time of biochemical failure with a prostate (12-core) and seminal vesicle (SV) (8-core) biopsy. The diagnostic properties of the scan and magnetic resonance imaging (MRI) in detecting SVI compared to an SV biopsy were calculated. In total, eight (14%) patients had a positive SV biopsy after primary in situ prostate cancer treatment. Nine (15%) patients had positive uptake of the scan in the SV. When comparing the SV scan results to the SV biopsy, the sensitivity, specificity, positive predictive value, and negative predictive value were 37.5%, 88.2%, 33.3%, and 90.0% (95% confidence interval: 0.44-0.81), respectively. In contrast, the ability of MRI to detect SVI was 50.0%, 81.3%, 40.0%, and 86.7% (95% confidence interval: 0.46-0.85), respectively. Although the sensitivity and positive predictive value of the (111)In-capromab pendetide/CT scan are low, its specificity and negative predictive value are high. Based on these findings, the ability of the (111)In-capromab pendetide/CT scan to detect SVI seems to be comparable with MRI.Keywords
This publication has 20 references indexed in Scilit:
- Use of Local 111In-Capromab Pendetide Scan Results to Predict Outcome After Salvage Radiotherapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Preoperative MR imaging in the evaluation of seminal vesicle invasion in prostate cancer: Pattern analysis of seminal vesicle lesionsJournal of Magnetic Resonance Imaging, 2008
- Single Photon Emission Computerized Tomography With Capromab Pendetide Plus Computerized Tomography Image Set Co-Registration Independently Predicts Biochemical FailureJournal of Urology, 2008
- The role of imaging in the detection of prostate cancer local recurrence after radiation therapy and surgeryCurrent Opinion in Urology, 2008
- Treatment failure after primary and salvage therapy for prostate cancerCancer, 2007
- Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Multi-institutional analysis of long-term outcome for stages T1–T2 prostate cancer treated with permanent seed implantationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- The Impact of a Negative 111 Indium-Capromab Pendetide Scan Before Salvage RadiotherapyJournal of Urology, 2006
- Clinical utility of indium 111‐capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomyCancer, 2002
- Original Articles: Prostate Cancer: The Use and Accuracy of Cross-Sectional Imaging and Fine Needle Aspiration Cytology for Detection of Pelvic Lymph Node Metastases Before Radical ProstatectomyJournal of Urology, 1995